Evaluation of the toxic potentials of a new camptothecin anticancer agent CKD-602 on fertility and early embryonic development in rats.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Regulatory toxicology and pharmacology : RTP

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YRTPH.2006.05.004PMID 16814440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comprar Histopathology of Preclinical Toxicity Studies, 3rd Edition. Interpretation and Relevance in Drug Safety Evaluation | Peter Greaves | 9780444527714 | Elsevier Science

  2007cited by this paper
• Camptothecin and Podophyllotoxin Derivatives

  2006cited by this paper
• Embryotoxic effects of CKD-602, a new camptothecin anticancer agent, in rats.

  2005cited by this paper
• 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs.

  2005cited by this paper
• Evaluation of spermatogenesis and fertility in F1 male rats after in utero and neonatal exposure to extremely low frequency electromagnetic fields.

  2005cited by this paper
• Effects of CKD-602, a New Camptothecin Anticancer Agent, on Pregnant Does and Embryo–Fetal Development in Rabbits

  2005cited by this paper
• Relationships Between Organ Weight and Body/Brain Weight in the Rat: What Is the Best Analytical Endpoint?

  2004cited by this paper
• Effects of prenatal exposure to the environmental pollutant 2-bromopropane on embryo-fetal development in rats.

  2004cited by this paper
• Subacute toxicity evaluation of a new camptothecin anticancer agent CKD-602 administered by intravenous injection to rats.

  2004cited by this paper
• The camptothecins.

  2003cited by this paper
• CKD-602. Chong Kun Dang.

  2003cited by this paper
• 26-Week repeated oral dose toxicity study of the new quinolone antibacterial DW-116 in Sprague-Dawley rats.

  2003cited by this paper
• Toxicity Patterns of Cytotoxic Drugs

  2003cited by this paper
• In Vitro pharmacodynamics of CKD-602 in HT-29 cells

  2002cited by this paper
• In vitro pharmacodynamics of CKD-602 in HT-29 cells

  2002cited by this paper
• The mechanism of topoisomerase I poisoning by a camptothecin analog

  2002cited by this paper
• Preformulation studies of a novel camptothecin anticancer agent, CKD-602: physicochemical characterization and hydrolytic equilibrium kinetics.

  2002cited by this paper
• Subchronic toxicity of plant sterol esters administered by gavage to Sprague-Dawley rats.

  2002cited by this paper
• Topoisomerase I interactive agents.

  2002cited by this paper
• Topoisomerase I interactive agents.

  2001cited by this paper
• Reproductive Endocrinology and Toxicological Pathology over the Life Span of the Female Rodent

  2001cited by this paper
• Preclinical and Phase I Clinical Studies with Ckd‐602, a Novel Camptothecin Derivative

  2000cited by this paper
• Multivariate statistical analysis of organ weights in toxicity studies.

  1999cited by this paper
• Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience

  1999cited by this paper
• Antitumor activity of 7-[2-(N-isopropylamino)ethyl]-(20S)-camptothecin, CKD602, as a potent DNA topoisomerase I inhibitor

  1998cited by this paper
• Clinical applications of the camptothecins.

  1998cited by this paper
• Fundamentals of Toxicologic Pathology

  1997cited by this paper
• Topoisomerase I inhibitors: review and update.

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• CPT-11: an original spectrum of clinical activity.

  1996cited by this paper
• Introduction: applications of amifostine in cancer treatment.

  1996cited by this paper
• Phase I and pharmacologic study of 9-aminocamptothecin given by 72-hour infusion in adult cancer patients.

  1996cited by this paper
• Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.

  1995cited by this paper
• Mutagenic activity of topoisomerase I inhibitors

  1995cited by this paper
• The current status of camptothecin analogues as antitumor agents.

  1993cited by this paper
• Properties of Sufficiency and Statistical Tests

  1992cited by this paper
• Pathology of the Fischer rat : reference and atlas

  1990cited by this paper
• Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity.

  1989cited by this paper
• Evaluation of rodent sperm, vaginal cytology, and reproductive organ weight data from National Toxicology Program 13-week studies.

  1988cited by this paper
• Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.

  1972cited by this paper
• Preliminary pharmacologic and clinical evaluation of camptothecin sodium (NSC-100880).

  1970cited by this paper
• New tables for multiple comparisons with a control.

  1964cited by this paper
• A METHOD FOR JUDGING ALL CONTRASTS IN THE ANALYSIS OF VARIANCE

  1953cited by this paper
• Use of Ranks in One-Criterion Variance Analysis

  1952cited by this paper
• Statistical Methods for Research Workers

  1937cited by this paper

• New Validated RP-HPLC Method for Cisplatin and Topotecan in API and Vaccine Form and its Stress Studies

  2021cites this paper
• Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems.

  2020cites this paper
• Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors.

  2020cites this paper
• Discovery of new thiophene, pyrazole, isoxazole derivatives as antitumor, c-Met, tyrosine kinase and Pim-1 kinase inhibitors

  2018cites this paper
• Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition.

  2018cites this paper
• The effects of N-acetyl-l-cysteine on the female reproductive performance and nephrotoxicity in rats

  2016cites this paper
• Nanotechnology approaches for inhalation treatment of lung diseases.

  2015cites this paper
• Ameliorative Effects of Pine Bark Extract on Spermatotoxicity by α‐Chlorohydrin in Rats

  2014cites this paper
• Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.

  2014cites this paper
• Substituted 4,5,6,7-tetrahydroindoles and their fused derivatives. Synthesis and cytotoxic activity towards tumor and normal human cell lines

  2013cites this paper
• Topoisomerase as target for antibacterial and anticancer drug discovery

  2013cites this paper
• Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.

  2012cites this paper
• Pycnogenol® prevents hexavalent chromium-induced spermatotoxicity in rats

  2012cites this paper
• Stress response to genotoxic agents and to infection

  2012cites this paper
• Amphiphilic Block Co-polyesters Bearing Pendant Cyclic Ketal Groups as Nanocarriers for Controlled Release of Camptothecin

  2011cites this paper
• Reproductive Toxic effects of cisplatin and Its Modulation by the Antioxidant sodium 2-Mercaptoethanesulfonate (Mesna) in Female Rats

  2011cites this paper
• Zinc at clinically-relevant concentrations potentiates the cytotoxicity of polysorbate 80, a non-ionic surfactant.

  2010cites this paper
• Glycolytic flux occurs in Drosophila melanogaster recovering from camptothecin treatment

  2010cites this paper
• Dose-Response Effects of Epichlorohydrin on Male Reproductive Function in Rats

  2009cites this paper
• Role of p53 family in birth defects: lessons from zebrafish.

  2008cites this paper
• Mother Nature's gifts to diseases of man: the impact of natural products on anti-infective, anticholestemics and anticancer drug discovery.

  2008cites this paper